Project Details
Status | Finished |
---|---|
Effective start/end date | 3/16/18 → 3/16/21 |
Funding
- ICON Clinical Research Limited ((OE) Prot #R668-AD-1652 // (OE) Prot #R668-AD-1652)
- Regeneron Pharmaceuticals, Inc. ((OE) Prot #R668-AD-1652 // (OE) Prot #R668-AD-1652)